Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shorter decrease » reported decrease (Expand Search), scores decreased (Expand Search), greater decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shorter decrease » reported decrease (Expand Search), scores decreased (Expand Search), greater decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
-
761
-
762
-
763
-
764
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
765
-
766
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
767
-
768
-
769
-
770
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
771
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
772
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
773
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
774
-
775
-
776
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
777
-
778
-
779
-
780
Weighted sociodemographic characteristics of the Kantar WorldPanel sample by year.
Published 2024Subjects: